10,411 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
GLBS Globus Maritime Limited $0.371 $11.88M N/A
Article Searches
Buying Snap at an all-time low is like buying a lottery ticket, strategist says https://www.cnbc.com/2018/10/11/buying-snap-at-all-time-low-like-buying-a-lottery-ticket-strategist.html Oct 11, 2018 - Snap is bouncing Thursday after plunging to an all-time low, but some say the worst isn't over for the long-suffering stock.
Even if Slack blows it, the company will still be 'many times larger' than it is today, CEO says https://www.cnbc.com/2018/10/11/slack-ceo-stewart-butterfield-says-company-will-be-many-times-larger.html Oct 11, 2018 - Slack is valued at more than $7 billion after a recent funding round in August.
Looking for a Growth Stock? Why It is Time to Focus on AB Volvo (VLVLY) http://www.zacks.com/stock/news/327365/looking-for-a-growth-stock-why-it-is-time-to-focus-on-ab-volvo-vlvly?cid=CS-ZC-FT-327365 Oct 11, 2018 - AB Volvo (VLVY) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Domo Sees Hammer Chart Pattern: Time to Buy? http://www.zacks.com/stock/news/327332/domo-sees-hammer-chart-pattern-time-to-buy?cid=CS-ZC-FT-327332 Oct 11, 2018 - Domo has been struggling lately, but the selling pressure may be coming to an end soon.
Country queen Loretta Lynn on all-female CMT lineup: 'It’s about dadgum time that we recognize women' http://www.latimes.com/entertainment/la-et-entertainment-news-updates-2018-loretta-lynn-thinks-it-s-about-dadgum-1539277012-htmlstory.html Oct 11, 2018 -
The best of times, the worst of times — for hospitality https://www.nrn.com/workforce/best-times-worst-times-hospitality Oct 10, 2018 - Depending who you ask, it’s either the golden age of hospitality — or it’s a terrible time for hospitality. Perhaps I’m simplifying the arguments too much here, but it sure was fun to watch restaurateurs duke it out at the American Cuisine and Hospit
Once upon a time, the Nets dreamed of winning a title. Now, it's all about taking baby steps toward being competitive http://www.nydailynews.com/sports/basketball/nets/ny-sports-nets-improving-20181010-story.html Oct 10, 2018 -

The Nets arrived in Brooklyn six years ago with big boasts about winning over New York and eventually winning a title.

They don't say much now at all.

There are no promises about how much they will win or how soon. In fact, they don't even really talk about winning.

The goal remains to be better,...

L.A. Times' Sam Farmer predicts winner of Eagles-Giants game on Thursday night http://www.latimes.com/sports/nfl/la-sp-eagles-giants-pick-20181010-story.html Oct 10, 2018 -

NFL Thursday


AT N.Y. GIANTS (1-4)

TV: Ch. 11, NFL Network, 5:15 p.m.

Line: Eagles by 3.

Over/under: 44.

Sam Farmer’s pick: The Eagles have a solid defense but significant offensive problems that are only amplified with the loss of running back Jay Ajayi. The Giants are backed...

Looking for Value? Why It Might Be Time to Try Arch Coal (ARCH) http://www.zacks.com/stock/news/327108/looking-for-value-why-it-might-be-time-to-try-arch-coal-arch?cid=CS-ZC-FT-327108 Oct 10, 2018 - Arch Coal (ARCH) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Cancer Research Highlight: Five Prime Moves To Prime Time With A New Phase 3 Trial Off The Ground https://seekingalpha.com/article/4210795-cancer-research-highlight-five-prime-moves-prime-time-new-phase-3-trial-ground?source=feed_sector_healthcare Oct 10, 2018 - Five Prime Therapeutics' main pipeline play is an FGFR2b antibody in gastric cancer.Recent news signals its move into the late stage of clinical development.Is there anything else to look forward to i

Pages: 123456789...1042

<<<Page 4>